Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions

Details for Australian Patent Application No. 2004277954 (hide)

Owner Warren Pharmaceuticals, Inc.

Inventors Yilmaz, Osman; Coleman, Thomas; Brines, Michael; Cerami, Anthony

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004277954

PCT Pub. Number WO2005/032467

Priority 60/506,149 29.09.03 US

Filing date 29 September 2004

Wipo publication date 14 April 2005

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 14/505 (2006.01) Peptides having more than 20 amino acids

C07K 14/555 (2006.01) Peptides having more than 20 amino acids

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/032467 Priority application(s): WO2005/032467

23 April 2009 Alteration of Name

  The name of the applicant has been altered to Warren Pharmaceuticals, Inc.; The Kenneth S Warren Institute, Inc.

22 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004277962-Removable stent

2004277951-Solubilized CoQ-10